Live
- DEO suspends teacher accused of sexual assault
- PM ‘cursing’ Congress out of despair: Maharashtra Cong Chief
- Applications are invited for Junior Colleges Scheme District Scheduled Castes Development Officer Ramlal
- A nomination was filed on the second day for the Nagar Kurnool parliamentary seat
- SP Gaikwad inspected the Telangana Amarnath Saleswaram Jatara yatra arrangements
- Rahul Gandhi's decision to contest from Wayanad shows 'lack of confidence': BJP President Nadda
- IPL 2024: Delhi bowlers will go after all of SRH’s top-order batters, says head coach Ricky Ponting
- At Amroha rally, PM Modi sends out ‘meaningful’ message for Muslims and Hindus
- Tripura records highest 79.83 pc voter turnout in Northeast
- The government has to clear the confusion
IIL sets up new SFF in Telangana State
Indian Immunologicals Ltd (IIL), a city-based biologicals company, Monday announced the ground-breaking of a new Sterile Filling Facility (SFF) at its manufacturing plant in Phase III of Genome Valley, in Ranga Reddy district, with an investment of Rs 75 crore.
Hyderabad: Indian Immunologicals Ltd (IIL), a city-based biologicals company, Monday announced the ground-breaking of a new Sterile Filling Facility (SFF) at its manufacturing plant in Phase III of Genome Valley, in Ranga Reddy district, with an investment of Rs 75 crore.
With this upcoming filling facility, the company expects to increase its capacity to supply lifesaving vaccines such as the Anti Rabies Vaccine (ARV) Abhayrab.
The new state-of-the-art facility expected to be ready later next year. The sterile filling facility is equipped with hi-end equipment from the world's best manufacturers, in line with the requirements of the nature of work handled at the plant, it said.
K Anand Kumar, Managing Director of IIL said the animal health and human health player has a long history of supplying vaccines critical to public health.
"We are constantly striving to make the vaccines affordable and accessible to reach the benefits of preventive healthcare to maximum number of people.
The expansion at Karkapatla plant is in line with our mission and will help meet the growing requirements of critical vaccines," he said.
